These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31618968)

  • 1. Liver Grafts with Major Extended Donor Criteria May Expand the Organ Pool for Patients with Hepatocellular Carcinoma.
    Lozanovski VJ; Kerr LTB; Khajeh E; Ghamarnejad O; Pfeiffenberger J; Hoffmann K; Chang DH; Mieth M; Longerich T; Strobel O; Weiss KH; Büchler MW; Mehrabi A
    J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31618968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of major extended donor criteria on graft failure and patient mortality after liver transplantation.
    Lozanovski VJ; Khajeh E; Fonouni H; Pfeiffenberger J; von Haken R; Brenner T; Mieth M; Schirmacher P; Michalski CW; Weiss KH; Büchler MW; Mehrabi A
    Langenbecks Arch Surg; 2018 Sep; 403(6):719-731. PubMed ID: 30112639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Declined Organs for Liver Transplantation: A Right Decision or a Missed Opportunity for Patients with Hepatocellular Carcinoma?
    Lozanovski VJ; Adigozalov S; Khajeh E; Ghamarnejad O; Aminizadeh E; Schleicher C; Hackert T; Müller-Stich BP; Merle U; Picardi S; Lund F; Chang DH; Mieth M; Fonouni H; Golriz M; Mehrabi A
    Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
    Lee EC; Kim SH; Shim JR; Park SJ
    Liver Transpl; 2018 Jan; 24(1):35-43. PubMed ID: 28885774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes utilizing imported liver grafts for recipients with hepatocellular carcinoma.
    Battula N; Reichman TW; Amiri Y; Carmody IC; Galliano G; Seal J; Bugeaud E; Bohorquez H; Bruce D; Cohen A; Loss GE
    Liver Transpl; 2017 Mar; 23(3):299-304. PubMed ID: 28026108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients Benefit from Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria without Harming the Health Care System.
    Gundlach JP; Linecker M; Dobbermann H; Wadle F; Becker T; Braun F
    Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
    McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
    Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation in the United States: a report from the Organ Procurement and Transplantation Network.
    Smith CM; Davies DB; McBride MA
    Clin Transpl; 2000; ():19-30. PubMed ID: 11512312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C Virus Recurrence Occurs Earlier in Patients Receiving Donation After Circulatory Death Liver Transplant Grafts Compared With Those Receiving Donation After Brainstem Death Grafts.
    Townsend SA; Monga MA; Nightingale P; Mutimer D; Elsharkawy AM; Holt A
    Transplant Proc; 2017 Nov; 49(9):2129-2134. PubMed ID: 29149973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One hundred in situ split-liver transplantations: a single-center experience.
    Yersiz H; Renz JF; Farmer DG; Hisatake GM; McDiarmid SV; Busuttil RW
    Ann Surg; 2003 Oct; 238(4):496-505; discussion 506-7. PubMed ID: 14530721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of degree of steatosis in extended criteria donor grafts with standardized histologic techniques: implications for graft survival.
    Frongillo F; Avolio AW; Nure E; Mulè A; Pepe G; Magalini SC; Agnes S
    Transplant Proc; 2009 May; 41(4):1268-72. PubMed ID: 19460535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
    Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
    Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longterm outcomes for whole and segmental liver grafts in adult and pediatric liver transplant recipients: a 10-year comparative analysis of 2,988 cases.
    Hong JC; Yersiz H; Farmer DG; Duffy JP; Ghobrial RM; Nonthasoot B; Collins TE; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2009 May; 208(5):682-9; discusion 689-91. PubMed ID: 19476815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver Transplantation With Livers From Octogenarians and a Nonagenarian.
    Dirican A; Soyer V; Koc S; Yagci MA; Sarici B; Onur A; Unal B; Yilmaz S
    Transplant Proc; 2015 Jun; 47(5):1323-5. PubMed ID: 26093710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended-criteria donors in liver transplantation Part II: reviewing the impact of extended-criteria donors on the complications and outcomes of liver transplantation.
    Nemes B; Gámán G; Polak WG; Gelley F; Hara T; Ono S; Baimakhanov Z; Piros L; Eguchi S
    Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):841-59. PubMed ID: 26831547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
    Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
    Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
    Yoon YI; Song GW; Lee SG; Hwang S; Kim KH; Kim SH; Kang WH; Cho HD; Jwa EK; Kwon JH; Tak EY; Kirchner VA
    J Hepatol; 2018 Jun; 68(6):1153-1162. PubMed ID: 29452208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extremely marginal liver grafts from deceased donors have outcome similar to ideal grafts.
    Goldaracena N; Quiñonez E; Méndez P; Anders M; Orozco Ganem F; Mastai R; McCormack L
    Transplant Proc; 2012 Sep; 44(7):2219-22. PubMed ID: 22974958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation in the United States: a report from the UNOS Liver Transplant Registry.
    Smith CM; Davies DB; McBride MA
    Clin Transpl; 1999; ():23-34. PubMed ID: 11038623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.
    Selzner M; Kashfi A; Cattral MS; Selzner N; Greig PD; Lilly L; McGilvray ID; Therapondos G; Adcock LE; Ghanekar A; Levy GA; Renner EL; Grant DR
    Liver Transpl; 2009 Dec; 15(12):1776-82. PubMed ID: 19938139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.